The Missing Story in Hormone Research: Why Women, Especially Asian Women, Have Been Left Behind

When we look at the history of medicine, it’s impossible not to notice one glaring truth: for centuries, medical science was built around men. Research was designed with men in mind, tested on men’s bodies, and assumed to apply equally to women. The study of hormones is a powerful example of this imbalance. From the earliest investigations into endocrine systems, men were seen as the default human subject, while women’s hormonal complexity was often labeled as “too difficult,” “too changeable,” or “too unpredictable.”

The modern study of hormones began in the late 19th and early 20th century, when scientists started to understand that glands in the body secreted substances—later named hormones—that influenced growth, metabolism, reproduction, and overall health. The discovery of insulin in 1921, for example, showed the world how profoundly hormones could impact life. Testosterone was isolated in the 1930s, sparking enormous interest in male hormones, virility, and performance. From there, much of early endocrinology revolved around male physiology. Women’s hormones, by contrast, were often viewed only in relation to fertility and reproduction. Instead of studying the broad impact of estrogen, progesterone, and other female hormones on the heart, brain, bones, or mood, research remained narrowly focused on menstruation, pregnancy, and childbirth.

This bias deepened over time. For decades, most clinical trials excluded women altogether. In the 1970s and 80s, researchers often justified this by arguing that women’s hormonal fluctuations during menstrual cycles would “complicate” results. The underlying assumption was that men were the stable, reliable subjects, and women’s biology was too messy to fit into neat scientific categories. As a result, even life-saving medications were tested almost entirely on men and then prescribed to women, often without proper knowledge of side effects or effectiveness. In fact, in 1993 the U.S. National Institutes of Health finally mandated that women be included in clinical research—showing just how recent the recognition of this gap really is.

This imbalance carried over into menopause research. For much of the 20th century, menopause was framed as a deficiency disease, with the loss of estrogen treated as something to be “fixed” with hormone replacement. The landmark Women’s Health Initiative (WHI) in the early 2000s shifted this narrative when it revealed risks associated with long-term hormone therapy. But here again, the majority of participants were Caucasian women in Western countries. Their experiences became the foundation for global menopause care, despite the fact that women in Asia, Africa, and other regions were not adequately represented.

The lack of diversity in hormone studies has serious consequences. We now know that cultural, dietary, and genetic factors shape how women experience menopause. For example, studies suggest that Japanese women report fewer hot flashes than Western women, possibly linked to diets higher in soy and phytoestrogens. Meanwhile, many Asian women experience different patterns of weight gain, bone loss, or cardiovascular risk compared to Caucasian women. Yet, because Asian women have been understudied, there is still limited data to guide tailored recommendations for diet, exercise, or supplementation in this region.

The consequences are not just academic—they are deeply personal. When women go to their doctors with symptoms of perimenopause or menopause, the advice they receive is often based on research conducted on populations that may not resemble them at all. An Asian woman in Malaysia, Singapore, or China may find that the solutions offered don’t fully address her needs. The gaps in research leave her feeling unseen and unheard, reinforcing the myth that symptoms must simply be endured as “normal.”

This is where we must change the narrative. The science of hormones cannot continue to center only on men, or only on Western women. We need broader, more inclusive research that recognizes the unique biology, culture, and lifestyle of women across the globe. We need to ask better questions: How does diet in Asia influence menopause symptoms? How do stress and cultural expectations shape the way women experience midlife changes? How can supplements be designed to reflect traditional wisdom and modern science in tandem?

The encouraging truth is that women no longer have to wait passively for science to catch up. With the information available today, we already know enough to make empowered choices. We know that balanced nutrition, regular movement, stress management, and natural support systems can significantly ease menopause symptoms. For Asian women, this may mean leveraging familiar foods like tofu, miso, leafy greens, turmeric, ginger, or red dates—ingredients long recognized in traditional practices for their restorative properties. It also means having access to products designed with women in mind, not as an afterthought but as the focus.

This is why solutions like M+ Balance exist. By combining plant-based ingredients backed by both tradition and modern science, M+ Balance addresses the core challenges of perimenopause and menopause: fatigue, mood swings, disrupted sleep, and reduced libido. It is created for women who may not have access to, or who may choose not to use, hormone replacement therapy. For Asian women, who have historically been overlooked in research, M+ Balance offers a way to bridge the gap, bringing together natural wisdom with targeted formulation.

As women, we deserve more than to be the footnote of medical research. We deserve solutions built for us, by us, and with us at the center. Aging is not something to fear—it is a natural part of life. But how we experience it depends greatly on the knowledge and resources we bring into it. By questioning the old narratives, by demanding more inclusive science, and by choosing supportive tools available to us today, we can transform menopause from a silent struggle into a season of strength.

The history of hormone research has been shaped by exclusion—first of women entirely, then of non-Western women specifically. But the future can look different if we insist on change. Imagine a world where a woman in Kuala Lumpur, Tokyo, or Delhi can walk into her doctor’s office and receive advice tailored to her genetics, her culture, and her needs. Imagine a world where menopause is not hidden but openly discussed, researched, and supported. That world begins with awareness, advocacy, and action.

We are standing at the edge of that shift now. The knowledge we have is enough to take meaningful steps, but the advocacy we push for will shape the future. The next generation of women should not inherit silence or neglect; they should inherit research that reflects their diversity and solutions that support their vitality.

The study of hormones may have begun with men, but it doesn’t have to end that way. We, as women, can reshape the narrative, and by doing so, we reshape the quality of our lives—not just for ourselves, but for all the women who will walk this path after us.